Switching from high doses of pure μ-opioid agonists to transdermal buprenorphine in patients with cancer: a feasibility study

Lena Lundorff, Per Sjøgren, Ole Bo Hansen, Torsten Jonsson, Per Rotbøll Nielsen, Lona Louring Christrup

Fingerprint

Dive into the research topics of 'Switching from high doses of pure μ-opioid agonists to transdermal buprenorphine in patients with cancer: a feasibility study'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science